Trial
NCT00965055
Ezetimibe in Patients Hypo-responsive to Statins
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
Merck Sharp & Dohme LLC
Condition
High Cholesterol
Intervention
Ezetimibe
Why stopped
The study was terminated due to inability to recruit subjects. A total of 2/100 anticipated were radomized.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-21